Tamoxifen study 2012

Home Forums VisTimer Features Suggestions Tamoxifen study 2012

Viewing 1 post (of 1 total)
  • Author
  • #1593

    Dec 5, 2012 In the worldwide Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) trial, 12
    894 women with early breast cancer who had completed 5 …In the worldwide Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) trial, 12
    894 …. We report the dataset of Aug 31, 2012, because in September, 2012 this …Mar 5, 2012 2012 Apr 20;30(12):1268-73. doi: 10.1200/JCO.2010.34.0141. … Project) B-24
    study demonstrated significant benefit with adjuvant tamoxifen …Feb 1, 2013 Results of the Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) study,
    reported at the 2012 San Antonio Breast Cancer Symposium and …Results From the ATLAS Study. Posted on December 6, 2012 … Earlier studies in
    the 1990s suggested that extending tamoxifen beyond five years not only …The latest in Our Milestones series: the story of tamoxifen, a discovery in …
    Category: Science blog October 15, 2012 Emma Smith2 comments … But the
    journey doesn't stop once a drug is approved for use – researchers continue to
    study and …Tamoxifen and Anastrozole As a Sequencing Strategy: A Randomized Controlled
    Trial in Postmenopausal Patients With Endocrine-Responsive Early Breast …01 November 2012 … The objective of this study was to elucidate whether
    estrogen, tamoxifen, and/or diet modification altered IL-1 levels in normal human
     …Dec 5, 2012 A study says that the breast cancer drug tamoxifen should be taken for 10 … But a
    new study suggests that women should be taking the drug for twice …. A version
    of this article appears in print on December 6, 2012, on Page …May 6, 2016 In women, the adverse effects (AEs) of tamoxifen have been well‐studied (Brown,
    2002; Fisher et al., 2005; Iqbal et al., 2012; Cuzick et al., …

Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.

Comments are Closed